Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment

J Am Heart Assoc. 2020 Jan 21;9(2):e013757. doi: 10.1161/JAHA.119.013757. Epub 2020 Jan 21.

Authors

Nicolas Palaskas¹, Juan Lopez-Mattei¹, Jean Bernard Durand¹, Cezar Iliescu¹, Anita Deswal^{1

2}

Affiliations

¹ Department of Cardiology The University of Texas MD Anderson Cancer Center Houston TX.
² Section of Cardiology Michael E. DeBakey VA Medical Center Baylor College of Medicine Houston TX.

No abstract available

Keywords: cardiotoxicity; immune checkpoint inhibitors; myocarditis.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Antineoplastic Agents, Immunological / adverse effects*
Biopsy
Cardiac Imaging Techniques
Cardiotoxicity
Electrocardiography
Heart / diagnostic imaging
Heart / drug effects*
Heart / physiopathology
Heart Disease Risk Factors
Humans
Molecular Targeted Therapy / adverse effects*
Myocarditis / chemically induced*
Myocarditis / diagnosis
Myocarditis / physiopathology
Myocarditis / therapy
Myocardium / pathology
Neoplasms / drug therapy*
Neoplasms / immunology
Prognosis
Risk Assessment

Substances

Antineoplastic Agents, Immunological